InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Eisenstadt Richard I. Director active across 1 company, notably Altimmune, Inc.. Cumulatively, 9 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €40k. Activity tracked since 31 July 2022. The latest transaction was disclosed on 30 January 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Richard I. Eisenstadt is Chief Financial Officer at Altimmune, Inc. (XNAS). He has filed 9 forms in total. Across the 9 recent filings we hold, the transactions span from 2022-08-03 to 2024-02-01, with EUR 39815 of buys and EUR 0 of sells, and the most common transaction nature is Levée d'options.